Citation Impact
Citing Papers
Anti-tissue transglutaminase antibodies from coeliac patients inhibit transglutaminase activity both in vitro and in situ
2002 Standout
Co-incidence of RCC-susceptibility polymorphisms with HIF cis-acting sequences supports a pathway tuning model of cancer
2019 StandoutNobel
Secretory phospholipase A2-IIa is involved in prostate cancer progression and may potentially serve as a biomarker for prostate cancer
2010
Computationally designed sensors detect endogenous Ras activity and signaling effectors at subcellular resolution
2024 StandoutNobel
Transcriptional Regulation of Cell Type-specific Expression of the TATA-less A Subunit Gene for Human Coagulation Factor XIII
1999
Activation of p21/ gene expression and inhibition of cell proliferation by overexpression of hepatocyte nuclear factor-4α
2004
Retinoic acid receptors: From molecular mechanisms to cancer therapy
2014
Hypomethylation of the MN/CA9 promoter and upregulated MN/CA9 expression in human renal cell carcinoma
2001
The history of cancer epigenetics
2004 Standout
Modulation of the in Situ Activity of Tissue Transglutaminase by Calcium and GTP
1998
Tissue transglutaminase: a possible role in neurodegenerative diseases
2000
Epigenetics in human disease and prospects for epigenetic therapy
2004 StandoutNature
Marine natural products
1990 Standout
Recent advances in organic mechanofluorochromic materials
2012 Standout
Identification of a Transforming Growth Factor-β1/Bone Morphogenetic Protein 4 (TGF-β1/BMP4) Response Element within the Mouse Tissue Transglutaminase Gene Promoter
1998
Molecular determinants of resistance to antiandrogen therapy
2003 Standout
Molecular Targets for Green Tea in Prostate Cancer Prevention
2003
Tissue transglutaminase: an enzyme with a split personality
1999
The RNA-binding protein Sam68 is a multifunctional player in human cancer
2011
X chromosome gene expression in human tissues: Male and female comparisons
2006
The development of androgen-independent prostate cancer
2001 Standout
Sp1 and krüppel‐like factor family of transcription factors in cell growth regulation and cancer
2001
Identification of novel hypoxia dependent and independent target genes of the von Hippel-Lindau (VHL) tumour suppressor by mRNA differential expression profiling
2000 StandoutNobel
Paxillin: Adapting to Change
2004
Transcript-level expression analysis of RNA-seq experiments with HISAT, StringTie and Ballgown
2016 Standout
p21 in cancer: intricate networks and multiple activities
2009 Standout
The cornified envelope: a model of cell death in the skin
2005 Standout
Transglutaminases: crosslinking enzymes with pleiotropic functions
2003 Standout
Retinoic Acid Receptors α and γ Mediate the Induction of “Tissue” Transglutaminase Activity and Apoptosis in Human Neuroblastoma Cells
1997
Cell adhesion: integrating cytoskeletal dynamics and cellular tension
2010 Standout
Cyclin D as a therapeutic target in cancer
2011
Common genetic variants at the 11q13.3 renal cancer susceptibility locus influence binding of HIF to an enhancer of cyclin D1 expression
2012 StandoutNobel
U1 snRNP regulates cancer cell migration and invasion in vitro
2020 Standout
Androgen action and metabolism in prostate cancer
2012
Aggregation-induced emission: phenomenon, mechanism and applications
2009 Standout
Evolution of Transglutaminase Genes: Identification of a Transglutaminase Gene Cluster on Human Chromosome 15q15
2001
Therapy-induced lipid uptake and remodeling underpin ferroptosis hypersensitivity in prostate cancer
2020
Androgen receptor as a target in androgen-independent prostate cancer
2002
A naphthalocyanine based near-infrared photosensitizer: Synthesis and in vitro photodynamic activities
2013
Identification of an additional hypoxia responsive element in the glyceraldehyde-3-phosphate dehydrogenase gene promoter
2002
Induction of Transcription Factor AP-2 by Cytokines and Prostaglandins in Cultured Mesangial Cells
2001
SZ‐685C, a marine anthraquinone, is a potent inducer of apoptosis with anticancer activity by suppression of the Akt/FOXO pathway
2010
Repertoire Enhancement with Adoptively Transferred Female Lymphocytes Controls the Growth of Pre-Implanted Murine Prostate Cancer
2012 StandoutNobel
Sphingosine Kinase-1 Is Central to Androgen-Regulated Prostate Cancer Growth and Survival
2009
Expression of Co-factors (SMRT and Trip-1) for Retinoic Acid Receptors in Human Neuroectodermal Cell Lines
1997
Truncating mutations of hSNF5/INI1 in aggressive paediatric cancer
1998 StandoutNature
Valproic acid defines a novel class of HDAC inhibitors inducing differentiation of transformed cells
2001 Standout
The CoQ oxidoreductase FSP1 acts parallel to GPX4 to inhibit ferroptosis
2019 StandoutNature
Revisiting STAT3 signalling in cancer: new and unexpected biological functions
2014 Standout
New sensing mechanisms for design of fluorescent chemosensors emerging in recent years
2011 Standout
Aggregation-induced emission
2011 Standout
Transcriptional Activation of the Human ucp1 Gene in a Rodent Cell Line
2000
Mechanisms and Consequences of Alternative Polyadenylation
2011
Interleukin-8 signaling promotes androgen-independent proliferation of prostate cancer cells via induction of androgen receptor expression and activation
2008
Molecular Regulation of Vascular Smooth Muscle Cell Differentiation in Development and Disease
2004 Standout
NF-κB, inflammation, immunity and cancer: coming of age
2018 Standout
Retinoids Regulate the Repairing Process of the Podocytes in Puromycin Aminonucleoside-induced Nephrotic Rats
2003 StandoutNobel
The history and future of targeting cyclin-dependent kinases in cancer therapy
2015 Standout
Intron-Exon Swapping of Transglutaminase mRNA and Neuronal Tau Aggregation in Alzheimer's Disease
2001
The Cyclins and Cyclin-Dependent Kinase Inhibitors in Hormonal Regulation of Proliferation and Differentiation*
1999
Photothermal therapy and photoacoustic imaging via nanotheranostics in fighting cancer
2018 Standout
Xenoestrogen Action in Prostate Cancer: Pleiotropic Effects Dependent on Androgen Receptor Status
2005
Nuclear Receptor Hepatocyte Nuclear Factor 4α1 Competes with Oncoprotein c-Myc for Control of the p21/WAF1 Promoter
2007
EDC-2: The Endocrine Society's Second Scientific Statement on Endocrine-Disrupting Chemicals
2015 Standout
Paradoxical Roles of Tumour Necrosis Factor-Alpha in Prostate Cancer Biology
2012
Structure of the STRA6 receptor for retinol uptake
2016 StandoutScienceNobel
Histone deacetylases (HDACs): characterization of the classical HDAC family
2003 Standout
Hoxa11 Regulates Stromal Cell Death and Proliferation during Neonatal Uterine Development
2003 StandoutNobel
Endocrine-Disrupting Chemicals: An Endocrine Society Scientific Statement
2009 Standout
Protein Crosslinking in Assembly and Remodelling of Extracellular Matrices: The Role of Transglutaminases
2000
Three-dimensional organization of promyelocytic leukemia nuclear bodies
2010 StandoutNobel
Androgen receptor expression in androgen-independent prostate cancer is associated with increased expression of androgen-regulated genes.
1998
Pomegranate fruit juice for chemoprevention and chemotherapy of prostate cancer
2005 Standout
Aggregation‐induced Emission (AIE)‐active Starburst Triarylamine Fluorophores as Potential Non‐doped Red Emitters for Organic Light‐emitting Diodes and Cl2 Gas Chemodosimeter
2007
Aggregation-Induced Emission: Together We Shine, United We Soar!
2015 Standout
Covalent cross‐linking of secreted bovine thyroglobulin by transglutaminase
2000
The Proximal Promoter of the Human Transglutaminase 3 Gene
1996
TNF-α modulates expression of the tissue transglutaminase gene in liver cells
1998
The Interleukin-8 Pathway in Cancer
2008 Standout
Nanotechnology for Multimodal Synergistic Cancer Therapy
2017 Standout
Nanoparticles in Photodynamic Therapy
2015 Standout
Brown Adipose Tissue: Function and Physiological Significance
2004 Standout
The development of anticancer ruthenium(ii ) complexes: from single molecule compounds to nanomaterials
2017 Standout
Physiological and Molecular Basis of Thyroid Hormone Action
2001 Standout
Oxidative Stress and Stress-Activated Signaling Pathways: A Unifying Hypothesis of Type 2 Diabetes
2002 Standout
Collocation of androgen receptor gene mutations in prostate cancer.
2001
Tissue Transglutaminase Is an Integrin-Binding Adhesion Coreceptor for Fibronectin
2000
Retinoid-induced differentiation of acute promyelocytic leukemia involves PML-RARalpha-mediated increase of type II transglutaminase
1996
Nuclear Receptor Coregulators: Cellular and Molecular Biology*
1999 Standout
Gene Disruption of Tissue Transglutaminase
2001
Reactive Oxygen Species (ROS)-Based Nanomedicine
2019 Standout
Recent advances in functional nanomaterials for light–triggered cancer therapy
2018
Claudins and the Modulation of Tight Junction Permeability
2013 Standout
Phospholipase A2Enzymes: Physical Structure, Biological Function, Disease Implication, Chemical Inhibition, and Therapeutic Intervention
2011 Standout
Oxygen-dependent regulation of mitochondrial respiration by hypoxia-inducible factor 1
2007 StandoutNobel
Overcoming the Achilles' heel of photodynamic therapy
2016
Mantle cell lymphoma cells express predominantly cyclin D1a isoform and are highly sensitive to selective inhibition of CDK4 kinase activity
2006
Fusion proteins of the retinoic acid receptor-α recruit histone deacetylase in promyelocytic leukaemia
1998 Nature
Role of Tissue Transglutaminase in Celiac Disease
2000
Novel bimodal effects of the G-protein tissue transglutaminase on adrenoreceptor signalling
1999
Retinoids in Embryonal Development
2000
Deconstructing a Disease: RAR, Its Fusion Partners, and Their Roles in the Pathogenesis of Acute Promyelocytic Leukemia
1999
Works of Shan Lu being referenced
Secretory phospholipase A2‐IIa is a target gene of the HER/HER2‐elicited pathway and a potential plasma biomarker for poor prognosis of prostate cancer
2011
Targeted Overexpression of Vav3 Oncogene in Prostatic Epithelium Induces Nonbacterial Prostatitis and Prostate Cancer
2008
Isolation and Characterization of the Human Tissue Transglutaminase Gene Promoter
1995
Androgen Induction of Cyclin-Dependent Kinase Inhibitor p21 Gene: Role of Androgen Receptor and Transcription Factor Sp1 Complex
2000
Identification and Characterization of a Versatile Retinoid Response Element (Retinoic Acid Receptor Response Element-Retinoid X Receptor Response Element) in the Mouse Tissue Transglutaminase Gene Promoter
1996
PI3K-Akt signaling is involved in the regulation of p21WAF/CIP expression and androgen-independent growth in prostate cancer cells
2006
Ultrafast Excited State Dynamics of Modified Phthalocyanines: p-HPcZn and p-HPcCo
2006
Regulation of the expression of the tissue transglutaminase gene by DNA methylation
1997
Regulation of androgen-dependent prostatic cancer cell growth: androgen regulation of CDK2, CDK4, and CKI p16 genes.
1997
Protonation salt derivative with heavy-atom effect on phthalocyanine for enhanced in vitro photodynamic therapy
2014
Molecular Mechanisms of Androgen-Independent Growth of Human Prostate Cancer LNCaP-AI Cells1
1999
Cyclin D1b variant influences prostate cancer growth through aberrant androgen receptor regulation
2006